‘Drug factory’ implants eliminate mesothelioma tumors in mice
A Baylor College of Medicine-Rice University collaboration is making strides in the treatment of mesothelioma and other cancers.
Read moreA Baylor College of Medicine-Rice University collaboration is making strides in the treatment of mesothelioma and other cancers.
Read moreA metabolic vulnerability in neuroblastoma could be exploited to overturn these tumors’ resistance to therapy.
Read moreA phase II clinical trial is on its way to assess the value of poziotinib in the treatment of this devastating condition.
Read moreThe findings support a diagnostic algorithm to identify the cancer subtype and guide specialized treatment.
Read moreBy taking a close look inside mesothelioma, Dr. B. Burt searches for clues to predict patient’s response to immunotherapy.
Read moreEndogenous mis-spliced RNA in tumor cells mimics an RNA virus, leading tumor cells to self-destruct as if fighting an infection.
Read moreNano-radiomics analysis of imaging data assesses changes in the tumor microenvironment that cannot be detected with conventional imaging methods.
Read moreEffectively treating upper tract urothelial cancer – a cancer of the lining of the kidney or the ureter, the long, thin tube that connects that
Read moreHistorically, cancer patients have been classified according to the organs where primary tumors present at diagnosis, and clinical trials commonly test drugs that are designed
Read moreWhen a mouse breast tumor is exposed to radio frequency (RF) electric fields the interaction between RF electric fields and the cancer tissue causes tumor vessels to
Read more